Charles River Labs Intl buy Bank of America Co.
Start price
15.12.25
/
50%
€168.60
Target price
15.12.26
€191.66
Performance (%)
25.21%
Price
28.07.26
€211.10
Summary
This prediction is currently active. The prediction currently has a performance of 25.21%. This prediction currently runs until 15.12.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Charles River Labs Intl | 2.754% | 2.754% |
| iShares Core DAX® | 2.992% | 3.220% |
| iShares Nasdaq 100 | -1.584% | -3.172% |
| iShares Nikkei 225® | -2.254% | -9.924% |
| iShares S&P 500 | -0.009% | 1.641% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $225.00 price target on the stock.
Ratings data for CRL provided by MarketBeat